Journal of Biological Chemistry · 2008 · 72 citations · 36 references
Life SciencesBiochemistryPharmacologyCellular MetabolismEnzymologyMetabolismMitochondrial BiochemistryMitochondrial MetabolismAldehyde Dehydrogenase CatalysisAldehyde Dehydrogenase MetabolismBovine Serum AlbuminCyclic Guanosine Monophosphate PathwayNitric OxideNitric Oxide MetabolismNitric Oxide ProductionNitric Oxide Signaling
Metabolism of nitroglycerin (GTN) to 1,2-glycerol dinitrate (GDN) and nitrite by mitochondrial aldehyde dehydrogenase (ALDH2) is essentially involved in GTN bioactivation resulting in cyclic GMP-mediated vascular relaxation. The link between nitrite formation and activation of soluble guanylate cyclase (sGC) is still unclear. To test the hypothesis that the ALDH2 reaction is sufficient for GTN bioactivation, we measured GTN-induced formation of cGMP by purified sGC in the presence of purified ALDH2 and used a Clark-type electrode to probe for nitric oxide (NO) formation. In addition, we studied whether GTN bioactivation is a specific feature of ALDH2 or is also catalyzed by the cytosolic isoform (ALDH1). Purified ALDH1 and ALDH2 metabolized GTN to 1,2- and 1,3-GDN with predominant formation of the 1,2-isomer that was inhibited by chloral hydrate (ALDH1 and ALDH2) and daidzin (ALDH2). GTN had no effect on sGC activity in the presence of bovine serum albumin but caused pronounced cGMP accumulation in the presence of ALDH1 or ALDH2. The effects of the ALDH isoforms were dependent on the amount of added protein and, like 1,2-GDN formation, were sensitive to ALDH inhibitors. GTN caused biphasic sGC activation with apparent EC50 values of 42 ± 2.9 and 3.1 ± 0.4 μm in the presence of ALDH1 and ALDH2, respectively. Incubation of ALDH1 or ALDH2 with GTN resulted in sustained, chloral hydrate-sensitive formation of NO. These data may explain the coupling of ALDH2-catalyzed GTN metabolism to sGC activation in vascular smooth muscle. Metabolism of nitroglycerin (GTN) to 1,2-glycerol dinitrate (GDN) and nitrite by mitochondrial aldehyde dehydrogenase (ALDH2) is essentially involved in GTN bioactivation resulting in cyclic GMP-mediated vascular relaxation. The link between nitrite formation and activation of soluble guanylate cyclase (sGC) is still unclear. To test the hypothesis that the ALDH2 reaction is sufficient for GTN bioactivation, we measured GTN-induced formation of cGMP by purified sGC in the presence of purified ALDH2 and used a Clark-type electrode to probe for nitric oxide (NO) formation. In addition, we studied whether GTN bioactivation is a specific feature of ALDH2 or is also catalyzed by the cytosolic isoform (ALDH1). Purified ALDH1 and ALDH2 metabolized GTN to 1,2- and 1,3-GDN with predominant formation of the 1,2-isomer that was inhibited by chloral hydrate (ALDH1 and ALDH2) and daidzin (ALDH2). GTN had no effect on sGC activity in the presence of bovine serum albumin but caused pronounced cGMP accumulation in the presence of ALDH1 or ALDH2. The effects of the ALDH isoforms were dependent on the amount of added protein and, like 1,2-GDN formation, were sensitive to ALDH inhibitors. GTN caused biphasic sGC activation with apparent EC50 values of 42 ± 2.9 and 3.1 ± 0.4 μm in the presence of ALDH1 and ALDH2, respectively. Incubation of ALDH1 or ALDH2 with GTN resulted in sustained, chloral hydrate-sensitive formation of NO. These data may explain the coupling of ALDH2-catalyzed GTN metabolism to sGC activation in vascular smooth muscle. The antianginal drug nitroglycerin (GTN) 2The abbreviations used are: GTN, nitroglycerin; GDN, glycerol dinitrate; BSA, bovine serum albumin; DEA/NO, 2,2-diethyl-1-nitroso-oxyhydrazine; DTT, dithiothreitol; GSH, glutathione; MES, 2-(N-morpholino)ethanesulfonic acid; ODQ, 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one; sGC, soluble guanylate cyclase. causes vasodilation through NO-mediated activation of sGC and cGMP accumulation in vascular smooth muscle (1Fung H.L. Annu. Rev. Pharmacol. Toxicol. 2004; 44: 67-85Crossref PubMed Scopus (118) Google Scholar). In virtually all cells and tissues, the slow reaction of GTN with thiols, in particular GSH, yields 1,2- and 1,3-GDN together with stoichiometric amounts of inorganic nitrite (2Bennett B.M. McDonald B.J. Nigam R. Simon W.C. Trends Pharmacol. Sci. 1994; 15: 245-249Abstract Full Text PDF PubMed Scopus (122) Google Scholar), but thiol-triggered GTN metabolism is not associated with GTN bioactivation except the still poorly understood reaction of GTN with l-cysteine that leads to formation of a bioactive species with NO-like properties (3Gorren A.C.F. Russwurm M. Kollau A. Koesling D. Schmidt K. Mayer B. Biochem. J. 2005; 390: 625-631Crossref PubMed Scopus (17) Google Scholar). Recently we have identified ascorbate as another endogenous reductant that causes non-enzymatic GTN bioactivation, but the reaction is slow and may not contribute significantly to the hemodynamic effects of GTN under normal physiological conditions (4Kollau A. Beretta M. Gorren A.C.F. Russwurm R. Koesling D. Schmidt K. Mayer B. Mol. Pharmacol. 2007; 72: 191-196Crossref PubMed Scopus (18) Google Scholar). Besides these non-enzymatic reactions, a number of enzymatic pathways catalyzing GTN bioactivation have been described, but it has remained unclear whether there is a distinct enzyme that mediates the vascular effects of GTN (1Fung H.L. Annu. Rev. Pharmacol. Toxicol. 2004; 44: 67-85Crossref PubMed Scopus (118) Google Scholar). Several years ago, ALDH2 (mitochondrial aldehyde dehydrogenase, EC 1.2.1.3), the main mitochondrial isoform of the ALDH superfamily, was proposed as a new candidate to fulfill this function (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar). The characteristics of ALDH2-catalyzed GTN metabolism, including relatively high GTN affinity (low micromolar) and selective formation of 1,2-GDN, rendered this pathway very promising, and several laboratories reported that pharmacological inhibition or gene deletion of ALDH2 led to significantly impaired GTN-induced vasorelaxation and vascular cGMP accumulation (6DiFabio J. Yanbin J. Vasiliou V. Thatcher R.J. Bennett B.M. Mol. Pharmacol. 2003; 64: 1109-1116Crossref PubMed Scopus (71) Google Scholar, 7Sydow K. Daiber A. Oelze M. Chen Z.P. August M. Wendt M. Ullrich V. Mülsch A. Schulz E. Keaney J.F. Stamler J.S. Münzel T. J. Clin. Investig. 2004; 113: 482-489Crossref PubMed Scopus (283) Google Scholar, 8Zhang J. Chen Z.P. Cobb F.R. Stamler J.S. Circulation. 2004; 110: 750-755Crossref PubMed Scopus (46) Google Scholar, 9Kollau A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar, 10Chen Z. Foster M.W. Zhang J. Mao L. Rockman H.A. Kawamoto T. Kitagawa K. Nakayama K.I. Hess D.T. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 12159-12164Crossref PubMed Scopus (192) Google Scholar). In addition, treatment of volunteers with an ALDH inhibitor attenuated the increase in forearm blood flow caused by GTN infusion to a similar degree as observed in East Asian subjects expressing a low activity mutant of ALDH2, indicating that this pathway contributes to the hemodynamic effects of GTN in humans (11Mackenzie I.S. Maki-Petaja K.M. McEniery C.M. Bao Y.P. Wallace S.M. Cheriyan J. Monteith S. Brown M.J. Wilkinson I.B. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 1891-1895Crossref PubMed Scopus (79) Google Scholar). There are three early reports on inhibition of ALDH by organic nitrates (12Komura S. Acta Pharmacol. Toxicol. 1974; 35: 145-154Crossref PubMed Scopus (8) Google Scholar, 13Towell J. Garthwaite T. Wang R. Alcohol Clin. Exp. Res. 1985; 9: 438-442Crossref PubMed Scopus (43) Google Scholar, 14Mukerjee N. Pietruszko R. J. Biol. Chem. 1994; 269: 21664-21669Abstract Full Text PDF PubMed Google Scholar), but the pharmacological implication of these observations had not been considered before the discovery of ALDH2-catalyzed GTN bioactivation by the Stamler laboratory in 2002 (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar). Mukerjee and Pietruszko (14Mukerjee N. Pietruszko R. J. Biol. Chem. 1994; 269: 21664-21669Abstract Full Text PDF PubMed Google Scholar) showed that the cytosolic and mitochondrial ALDH isoforms are inactivated by isosorbide dinitrate in a mechanism-based manner, whereby the reversibility of enzyme inactivation by 2-mercaptoethanol suggested the involvement of sulfhydryl oxidation. Later studies confirmed and extended these observations, showing that the presence of a reductant is essential for sustained ALDH2-catalyzed GTN metabolism and bioactivation (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar, 9Kollau A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). Intriguingly, the most abundant cellular reductant, GSH, is ineffective, raising the question for the identity of the physiological reductant. A promising candidate is dihydrolipoic acid, which was shown to restore ALDH2 activity in GTN-exposed blood vessels (15Wenzel P. Hink U. Oelze M. Schuppan S. Schaeuble K. Schildknecht S. Ho K.K. Weiner H. Bachschmid M. Münzel T. Daiber A. J. Biol. Chem. 2007; 282: 792-799Abstract Full Text Full Text PDF PubMed Scopus (146) Google Scholar). However, enzyme reactivation required relatively high concentrations of the reductant, and evidence for a role of endogenous dihydrolipoic acid in GTN bioactivation is still missing. This issue is of considerable pharmacological interest because vascular depletion of the endogenous ALDH2 reductant may at least partially explain the phenomenon of nitrate tolerance, i.e. the loss of vascular sensitivity to GTN upon continuous application because of impaired GTN bioactivation (16Münzel T. Daiber A. Mülsch A. Circ. Res. 2005; 97: 618-628Crossref PubMed Scopus (361) Google Scholar). Notwithstanding the large body of evidence for a significant contribution of ALDH2 to vascular GTN bioactivation, it is still unclear how the ALDH2 reaction, yielding inorganic nitrite as final product, is linked to sGC activation. One possibility would be that nitrite formation is coupled to a nitrite reductase pathway associated with the mitochondrial respiratory chain (17Chen Z. Stamler J.S. Trends Cardiovasc. Med. PubMed Scopus Google Scholar). In of this were to nitrite to in the presence of respiratory at low K. H. PubMed Scopus Google Scholar), activation of T. Z. Full Text Full Text PDF PubMed Scopus Google Scholar). In a we confirmed these observations but no between mitochondrial respiratory and sGC M. M. D. M. K. and B. for indicating that mitochondrial nitrite is not essential for GTN bioactivation to In of we have suggested that ALDH2 may formation of GTN A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). However, this was on data and has not been considered by we a to whether GTN metabolism catalyzed by purified ALDH2 in formation and activation of In addition, we to whether the to GTN bioactivation is a specific feature of ALDH2. we that ALDH1 aldehyde dehydrogenase, EC and ALDH2 are to GTN to low GTN affinity of ALDH1 may the contribution of this isoform to GTN bioactivation in sGC was purified as M. Koesling D. 2005; PubMed Scopus Google Scholar). and were GTN in were a were in and were was and in of were in and with in was by of bovine with as K. P. Mayer B. Biochem. J. 1994; PubMed Scopus Google Scholar). was as W.M. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar) and in at μm of were ALDH and ALDH1 and ALDH2 were in as Wang Weiner H. Alcohol Clin. Exp. Res. PubMed Scopus Google Scholar), as the for ALDH2 was purified by affinity as Weiner H. PubMed Scopus Google Scholar). final the protein was on a which had been in and with the at ALDH1 was purified to the but the final the were and and of ALDH and activity was measured as formation of in the presence of concentrations of by the increase in at at Keung W.M. 35: PubMed Scopus Google Scholar). The was or (ALDH2). reported K.K. A. Weiner H. 2005; 44: PubMed Scopus Google Scholar), we observed that the dehydrogenase activity of ALDH1 but the activity of ALDH2 The of isoforms were by in the presence of not activity was measured by formation of concentrations of in the presence of The were the as for of dehydrogenase were by the data to the of 1,2- and 1,3-GDN by of GTN metabolism yielding 1,2- and 1,3-GDN was to a A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). purified ALDH1 or ALDH2 of was with GTN at for in a final of of GSH, DTT, and GTN as required to the final The amount of added was for of reaction at GTN concentrations hydrate and the were as in the and were with of by and by values were in the of protein under conditions and are as of and of values ± were reaction measured as in three of sGC bovine sGC was at for in a final of with the concentrations of and in the and presence of purified ALDH1 or ALDH2 or as in the and and chloral hydrate or daidzin or was were by the of of and of by and of as E. J. of Scholar). values were in the of of in the of Purified ALDH formation was measured with a Clark-type electrode with nitrite as B. P. Schmidt K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), in of DTT, and GTN and with ALDH1 and ALDH2, The was were in the presence of the or or the ALDH inhibitor chloral hydrate at purified ALDH1 or ALDH2 which had been to for was The μm final was added in to that the observed formation of of the of in ALDH1 and ALDH2, protein were with nitric acid final and for The were for with an coupled in the of was as The concentrations of and were were not of Purified ALDH the E. were as by not The enzyme for the dehydrogenase and of ALDH1 and ALDH2 including the significantly values for aldehyde and and specific activity of ALDH2, with values reported Keung W.M. 35: PubMed Scopus Google of purified ALDH1 and ± ± ± ± ± ± ± ± in a new GTN of 1,2- and 1,3-GDN formation by that ALDH isoforms GTN metabolism ALDH1 μm GTN 1,2- and 1,3-GDN with of ± and ± respectively. In the presence of this low GTN ALDH2 activity with to 1,2-GDN formation ± of 1,3-GDN was very low ± the selective of GTN the 1,2-isomer under these conditions (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar, 9Kollau A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). chloral hydrate inhibited GTN metabolism by daidzin showed for ALDH2. by the GTN of the shown in the isoforms similar of but significantly in GTN affinity and of 1,2-GDN by ALDH1 and ALDH2 was at and μm GTN, the values of ALDH2 measured with dehydrogenase and reported (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar, 9Kollau A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar), specific 1,2-GDN formation by ALDH2 was at GTN formation of the not 1,2-GDN formation at In the reaction resulted in predominant formation of the at In the of 1,2-GDN formation was significantly at the GTN of 1,3-GDN was not by indicating that it not of GTN to the of the on GTN of 1,2- and 1,3-GDN formation by ALDH1 and ALDH2 Purified ALDH1 and ALDH2 of were at for in the presence of GSH, DTT, and the concentrations of 1,2- and 1,3-GDN were and by as under values ± of three GTN as of sGC was used for sensitive of associated with GTN the GTN of the ALDH GTN was at final concentrations of and μm in the with ALDH1 and ALDH2, respectively. shown in cGMP was not in the presence of amounts of that was used as a protein activity between ± and ± of cGMP In the of GTN, ALDH1 ALDH2 cGMP formation for GTN However, the presence of GTN and ALDH1 or ALDH2 led to significant sGC activation. The effects of the ALDH isoforms were dependent on the amount of added of cGMP formation were observed with of ALDH1 or of sGC activity a or at ALDH concentrations and of the measured with of GTN on sGC activation. Purified sGC was with ALDH1 or ALDH2 or as in the to in the presence of the concentrations of was and as under are values ± of three To whether GTN bioactivation the of the we the effects of the ALDH chloral hydrate and daidzin To for inhibition of of sGC the effects of the added are shown as the of sGC activity under conditions in the presence of μm the chloral hydrate inhibited GTN-induced sGC activation by ALDH1 and ALDH2, daidzin the effect of ALDH2, that of GTN to the of the ALDH isoforms is essential for The involvement of to the of sGC was with the sGC inhibitor J. E. Schmidt K. Mayer B. Mol. Pharmacol. Google Scholar, A. S. Schmidt K. Koesling D. Mayer B. Mol. Pharmacol. Google Scholar), the S. A. Schmidt K. Mayer B. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, A. Gorren A.C.F. Schmidt K. S. Mayer B. Biol. Med. 2003; PubMed Scopus (122) Google Scholar), and the shown in all three inhibited sGC activation by the GTN of cGMP formation in the presence of ALDH1 and ALDH2. The effects of GTN were biphasic with apparent EC50 values of 42 ± 2.9 μm and 3.1 ± 0.4 μm (ALDH2). The of GTN to sGC in the presence of ALDH2 with the metabolism shown in a affinity of the nitrate for the mitochondrial GTN had no effect in the presence of BSA, which as a protein of sGC by GTN was not by the acid not GTN in of of sGC activation by and suggested the involvement of in GTN we to with a Clark-type In we observed relatively that were and in the presence of not To this apparent all were in the presence of of conditions were to GTN bioactivation to the sGC shown in of ALDH1 or ALDH2 to resulted in the of pronounced with of ± and ± μm respectively. The concentrations measured with ALDH1 and ALDH2 were ± and ± respectively. were observed in the presence of chloral hydrate hydrate not not The apparent formation by isoforms was by which GTN The of formation ± and ± μm ALDH1 and ALDH2, and concentrations ± μm ALDH1 and ± μm that formation may nitrite and as a formation in of and but the effects were pronounced observed with by ALDH1 or ALDH2 upon of indicating that the formation of of ALDH2 GTN to inorganic nitrite (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar), we that the observed formation be to nitrite reductase activity of the ALDH To test this we used nitrite of GTN in sGC as ALDH To non-enzymatic bioactivation of the were in the of shown in sGC a specific activity of ± in the presence of This activity was or in the presence of ALDH1 or ALDH2, respectively. hydrate had no effect on sGC activity in the presence of nitrite but inhibited the effects of ALDH1 and ALDH2, protein The that GTN metabolism catalyzed by purified ALDH isoforms is associated with formation of resulting in pronounced sGC activation. that enzymatic nitrite by the respiratory chain not to contribute significantly to mitochondrial GTN these may a and for reports showing that ALDH2-catalyzed GTN metabolism accumulation of cGMP in blood vessels (5Chen Z.Q. Zhang J. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 8306-8311Crossref PubMed Scopus (496) Google Scholar, 9Kollau A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). The of formation measured in the presence of and that formation for of GTN under conditions However, the of the that we observed in the presence of of that the have been because of This is for the degree of sGC which had to be measured in the of and to of these with the enzyme specific activity and, in sGC activation measured under conditions most the of the of GTN The pronounced effect of on not significant of in may be GTN which was shown to formation in blood vascular S. B. M. D. E. J. Pharmacol. Exp. Google Scholar, B. S. E. Biol. Med. PubMed Scopus Google Scholar, T. H. H. Hink U. E. M. Oelze M. M. A. L. T. U. Circ. Res. PubMed Google Scholar). In addition, we that DTT, which was to mechanism-based ALDH caused of that was by Schmidt and B. This apparent may be to in R. T. Biol. 2005; PubMed Scopus Google Scholar). of is the degree of sGC activation by GTN in and may explain the biphasic GTN shown in In addition, as studied in (3Gorren A.C.F. Russwurm M. Kollau A. Koesling D. Schmidt K. Mayer B. Biochem. J. 2005; 390: 625-631Crossref PubMed Scopus (17) Google Scholar), of by high concentrations of GTN may NO-mediated sGC activation. However, of these to explain sGC activation by a of GTN in the presence of amounts of ALDH the of was not by of the not GTN bioactivation may have been under conditions by a mechanism-based pathway that to be of evidence that GTN bioactivation the of sGC activation and formation were by ALDH inhibitors. In with the of the W.M. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, Keung W.M. 35: PubMed Scopus Google Scholar), chloral hydrate attenuated GTN bioactivation by ALDH1 and ALDH2, daidzin with the ALDH2-catalyzed GTN an of the nitrate to sGC in the presence of ALDH2 with This in the apparent GTN is in with the in the values of the isoforms for aldehyde and data with ALDH1 that the of GTN 1,2- and 1,3-GDN is not a specific feature of ALDH2, a reaction to ALDH similar characteristics of and ALDH2-catalyzed GTN metabolism with to by and formation of 1,2-GDN at low GTN there were also Besides the GTN concentrations required for activity of significantly between the In to ALDH2, ALDH1 1,3-GDN at GTN and the of 1,2-GDN formation was by at the GTN with indicating that GTN metabolism is dependent on the presence of the ALDH2-catalyzed reaction, M. and B. these to in the properties of the studies on the and function of and ALDH isoforms the of these The that of GTN bioactivation is not a specific feature of ALDH2 is with to ALDH but the pharmacological of this is unclear. The low apparent GTN affinity of ALDH1 is to the contribution of this isoform to GTN bioactivation in with low of the ALDH1 or isoforms of catalyzing this reaction contribute to the pathway of GTN (17Chen Z. Stamler J.S. Trends Cardiovasc. Med. PubMed Scopus Google Scholar) that upon ALDH2 inhibition (6DiFabio J. Yanbin J. Vasiliou V. Thatcher R.J. Bennett B.M. Mol. Pharmacol. 2003; 64: 1109-1116Crossref PubMed Scopus (71) Google Scholar, 9Kollau A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar) or gene deletion Z. Foster M.W. Zhang J. Mao L. Rockman H.A. Kawamoto T. Kitagawa K. Nakayama K.I. Hess D.T. Stamler J.S. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 12159-12164Crossref PubMed Scopus (192) Google Scholar). we that GTN bioactivation catalyzed by was sensitive to chloral hydrate but not to daidzin A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). the data that ALDH1 and isoforms of the enzyme contribute to the low affinity of GTN in blood we the the observed formation of in the of GTN The significantly activation of sGC by inorganic nitrite in the presence of the purified ALDH isoforms that the are of nitrite to that of nitrite bioactivation by chloral hydrate effects of the and that formation the of the However, activation of sGC by nitrite was and required high nitrite the of this reaction for formation of NO. because the sGC were under i.e. in the of and because of of these with the the of the reaction may be are a cGMP with K. H. U. F. J. Google Scholar) to of the sGC The high nitrite that was required for sGC activation may low affinity of nitrite to the but not that nitrite to in in the of the enzymatic the data are not sufficient to nitrite as an were this nitrite reductase activity of ALDH or of nitrite in the data with ALDH2 that the in the is essential for formation and sGC the of formation may be a of GTN at yielding a shown in this be to through to a nitrite leads to to and However, this pathway would in inactivation of the enzyme because of of and it not explain GTN bioactivation is by but not by or reaction of the Bennett B.M. V. Biol. Med. 2004; PubMed Scopus Google Scholar) with an would in formation of and a This pathway inactivation of ALDH2 by GTN as as the of not in but the of effect of acid the involvement of a However, with is required to this has been shown that vascular GTN metabolism in of that may be as an of GTN bioactivation H.L. Biochem. Pharmacol. PubMed Scopus Google Scholar). The NO-like properties of as may be by of to by or K.M. N. T. E. M. Proc. Natl. Acad. Sci. U. S. A. 2003; PubMed Scopus Google Scholar). the acid had no significant effect on sGC and the purified ALDH not significant amounts of we as an of GTN the that ALDH1 and ALDH2 GTN significant amounts of NO. is to whether this formation of GTN-induced cGMP formation in we that of cGMP accumulation in blood vessels is sufficient for vascular A. Hofer A. Russwurm M. Koesling D. Keung W.M. Schmidt K. Brunner F. Mayer B. Biochem. J. 2005; 385: 769-777Crossref PubMed Scopus (79) Google Scholar). activation of sGC by GTN as observed in the presence of purified ALDH isoforms may for the vascular effects of the nitrate in we the of pathways GTN metabolism to sGC activation in vascular smooth muscle studies are to the of and the formation.
36
Journal of AOAC INTERNATIONAL · 1975 · 19.9K citations
International Journal of Biochemistry · 1985 · 3.5K citations